No Data
No Data
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Share Price Could Signal Some Risk
HOB Biotech Names Chief Financial Officer; Shares Up 6%
Haobo (688656.SH): Zhang Yangqing has been appointed as the company's chief financial officer.
On April 16, Gelonghui reported that Haobol (688656.SH) announced that the company's Board of Directors recently received a written resignation letter from the financial director, Ms. Han Shuyan, who applied to resign from her position due to work adjustments. After her resignation, Ms. Han Shuyan will continue to serve in the company. To ensure the smooth operation of the company's financial management, in accordance with relevant laws, regulations, normative documents, and the company's articles of association, and based on the nomination by the company's general manager, the Board of Directors' Nomination Committee and the Board of Directors' Audit Committee reviewed and approved it. The company will hold the second meeting of the third Board of Directors on April 16, 2025.
Haoaobo (688656.SH): Some Directors and senior management personnel have resigned.
On April 16, Gelonghui announced that the Board of Directors recently received written resignation letters from Mr. Wang Kai, a director, Mr. Liu Qingxin, a director and deputy general manager, Mr. Xiong Feng, a director, Mr. Sun Ruoliang, a deputy general manager, and Ms. Huang Xiaohua.
Haooubo (688656.SH): Currently, DeepSeek has not been deployed.
On March 27, Gelonghui reported that Haobor (688656.SH) stated on the investor interaction platform that the company has not yet deployed DeepSeek.
The performance in the first year of the bet was thrilling without danger. "The first stock for allergen detection on the Star" Haobor's pressure is beginning to show.
①In 2024, Haobor "barely" achieved its first year's betting target after deducting specific Business; ②2024 marks the first time in seven years that the company's Net income falls below 40 million yuan, and it is also the lowest since landing on the Star.